...

首页> 外文期刊>Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners >Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study

【24h】

Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study

机译：用IPILIMIMAB治疗粘膜和眼黑素瘤患者存活的预后因素：土耳其肿瘤学群体研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：客观的

著录项

来源
《Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners》 |2020年第2期|共6页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
Ipilimumab; uveal melanoma; mucosal melanoma; prognostic factors;

机译：IPILIMIMAB;UVEAL黑色素瘤;粘膜黑色素瘤;预后因素;

相似文献

外文文献
中文文献
专利

1. Tescalcin调节细胞增殖和存活是肝癌患者不良预后因素 [J] . 周仲国, 徐立, 陈敏山, 癌症（英文版） . 2021,第006期
2. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study [J] . Journal of international management . 2020,第2期

机译：用IPILIMIMAB治疗粘膜和眼黑素瘤患者存活的预后因素：土耳其肿瘤学群体研究
3. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study [J] . Urun Yuksel, Yasar H. Arzu, Turna Hande, Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners . 2019,第7期

机译：用IPILIMIMAB治疗转移性恶性黑色素患者存活的预后因素：土耳其肿瘤学群体研究
4. Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study" [J] . Yilmaz Melek Tugce, Elmali Aysenur, Yazici Gozde Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners . 2019,第8期

机译：对IPILIMIMAB治疗的“转移性恶性黑素瘤患者存活的预后因素”评论：土耳其肿瘤学群体研究“
5. Prognostic imaging defined risk factors for survival time of neuroblastoma patients in Bulgaria [C] . Georgi Valchev, Krasimira Prodanova International Conference on Application of Mathematics in Engineering and Economics . 2019

机译：保加利亚神经母细胞瘤患者存活时间的预后成像定义的风险因素
6. Prognostic significance of some clinical, histopathological and biological parameters for survival of node-negative breast cancer patients treated in University Medical centre Maribor in the period 2000-2009 [D] . Fokter Dovnik, Nina. 2017

机译：2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床，组织病理学和生物学参数的预后意义
7. Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study [O] . Paola Queirolo, Beatrice Dozin, Anna Morabito, -1

机译：更正：CTLA-4基因变异与伊匹木单抗治疗的转移性黑素瘤患者对治疗反应和长期生存的联系：一项意大利黑素瘤研究
8. Prognostic factors for efficacy of Ipilimumab used after anti-PD1 and/or BRAF+MEK inhibitors in melanoma patients: An Italian melanoma intergroup study [O] . R. Marconcini, A. Nuzzo, S. Manacorda, 2019

机译：黑色素瘤患者抗PD1和/或BRAF + MEK抑制剂中使用的IPILIMIMAB疗效的预后因素：意大利黑色素瘤杂交研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号